Search by Drug Name or NDC

    NDC 68462-0166-15 fingolimod 0.5 mg/1 Details

    fingolimod 0.5 mg/1

    fingolimod is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is FINGOLIMOD HYDROCHLORIDE.

    Product Information

    NDC 68462-0166
    Product ID 68462-166_2581e472-3525-45d0-abf1-536df92793b4
    Associated GPIs
    GCN Sequence Number 066709
    GCN Sequence Number Description fingolimod HCl CAPSULE 0.5 MG ORAL
    HIC3 H0E
    HIC3 Description AGENTS TO TREAT MULTIPLE SCLEROSIS
    GCN 29073
    HICL Sequence Number 037180
    HICL Sequence Number Description FINGOLIMOD HCL
    Brand/Generic Generic
    Proprietary Name fingolimod
    Proprietary Name Suffix n/a
    Non-Proprietary Name fingolimod
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/1
    Substance Name FINGOLIMOD HYDROCHLORIDE
    Labeler Name Glenmark Pharmaceuticals Inc., USA
    Pharmaceutical Class Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207985
    Listing Certified Through 2024-12-31

    Package

    NDC 68462-0166-15 (68462016615)

    NDC Package Code 68462-166-15
    Billing NDC 68462016615
    Package 28 CARTON in 1 CARTON (68462-166-15) / 14 BLISTER PACK in 1 CARTON / 14 CAPSULE in 1 BLISTER PACK
    Marketing Start Date 2022-09-28
    NDC Exclude Flag N
    Pricing Information N/A